Kiyomitsu received his PhD at Tohoku University in Japan and is currently a pharmacologist of the pharmaceutical company Astellas Pharma Inc.
Drug targeting for suppression of inflammation in murine models of autoimmunity.
Kiyomitsu received his PhD at Tohoku University in Japan and is currently a pharmacologist of the pharmaceutical company Astellas Pharma Inc.
Drug targeting for suppression of inflammation in murine models of autoimmunity.